Tamil S Anthonymuthu1,2,3, Elizabeth M Kenny1,2,3, Andrew M Lamade1,2,3, Hitesh Gidwani1, Nicholas M Krehel1, Amalea Misse1, Xiaotian Gao4, Andrew A Amoscato2,5, Adam C Straub6,7, Valerian E Kagan2,5,6,8, Cameron Dezfulian1,6, Hülya Bayır1,2,3,5. 1. Safar Center for Resuscitation Research, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA. 2. Center for Free radical and Antioxidant Health, University of Pittsburgh, Pittsburgh, PA. 3. Children's Neuroscience Institute, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA. 4. Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA. 5. Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA. 6. Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA. 7. Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA. 8. Laboratory of Navigational Redox Lipidomics, IM Sechenov Moscow State Medical University, Moscow, Russian Federation.
Abstract
OBJECTIVES: Brain mitochondrial dysfunction limits neurologic recovery after cardiac arrest. Brain polyunsaturated cardiolipins, mitochondria-unique and functionally essential phospholipids, have unprecedented diversification. Since brain cardiolipins are not present in plasma normally, we hypothesized their appearance would correlate with brain injury severity early after cardiac arrest and return of spontaneous circulation. DESIGN: Observational case-control study. SETTING: Two medical centers within one city. PARTICIPANTS (SUBJECTS): We enrolled 41 adult cardiac arrest patients in whom blood could be obtained within 6 hours of resuscitation. Two subjects were excluded following outlier analysis. Ten healthy subjects were controls. Sprague-Dawley rats were used in asphyxial cardiac arrest studies. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We developed a high-resolution liquid chromatography/mass spectrometry method and determined cardiolipins speciation in human brain, heart, and plasma within 6 hours of (return of spontaneous circulation) from 39 patients with cardiac arrest, 5 with myocardial infarction, and 10 healthy controls. Cerebral score was derived from brain-specific cardiolipins identified in plasma of patients with varying neurologic injury and outcome. Using a rat model of cardiac arrest, cardiolipins were quantified in plasma, brain, and heart. Human brain exhibited a highly diverse cardiolipinome compared with heart that allowed the identification of brain-specific cardiolipins. Nine of 26 brain-specific cardiolipins were detected in plasma and correlated with brain injury. The cerebral score correlated with early neurologic injury and predicted discharge neurologic/functional outcome. Cardiolipin (70:5) emerged as a potential point-of-care marker predicting injury severity and outcome. In rat cardiac arrest, a significant reduction in hippocampal cardiolipins corresponded to their release from the brain into systemic circulation. Cerebral score was significantly increased in 10 minutes versus 5 minutes no-flow cardiac arrest and naïve controls. CONCLUSIONS: Brain-specific cardiolipins accumulate in plasma early after return of spontaneous circulation and proportional to neurologic injury representing a promising novel biomarker.
OBJECTIVES: Brain mitochondrial dysfunction limits neurologic recovery after cardiac arrest. Brain polyunsaturated cardiolipins, mitochondria-unique and functionally essential phospholipids, have unprecedented diversification. Since brain cardiolipins are not present in plasma normally, we hypothesized their appearance would correlate with brain injury severity early after cardiac arrest and return of spontaneous circulation. DESIGN: Observational case-control study. SETTING: Two medical centers within one city. PARTICIPANTS (SUBJECTS): We enrolled 41 adult cardiac arrestpatients in whom blood could be obtained within 6 hours of resuscitation. Two subjects were excluded following outlier analysis. Ten healthy subjects were controls. Sprague-Dawley rats were used in asphyxial cardiac arrest studies. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We developed a high-resolution liquid chromatography/mass spectrometry method and determined cardiolipins speciation in human brain, heart, and plasma within 6 hours of (return of spontaneous circulation) from 39 patients with cardiac arrest, 5 with myocardial infarction, and 10 healthy controls. Cerebral score was derived from brain-specific cardiolipins identified in plasma of patients with varying neurologic injury and outcome. Using a rat model of cardiac arrest, cardiolipins were quantified in plasma, brain, and heart. Human brain exhibited a highly diverse cardiolipinome compared with heart that allowed the identification of brain-specific cardiolipins. Nine of 26 brain-specific cardiolipins were detected in plasma and correlated with brain injury. The cerebral score correlated with early neurologic injury and predicted discharge neurologic/functional outcome. Cardiolipin (70:5) emerged as a potential point-of-care marker predicting injury severity and outcome. In ratcardiac arrest, a significant reduction in hippocampal cardiolipins corresponded to their release from the brain into systemic circulation. Cerebral score was significantly increased in 10 minutes versus 5 minutes no-flow cardiac arrest and naïve controls. CONCLUSIONS: Brain-specific cardiolipins accumulate in plasma early after return of spontaneous circulation and proportional to neurologic injury representing a promising novel biomarker.
Authors: Jonathan Elmer; Cesar Torres; Tom P Aufderheide; Michael A Austin; Clifton W Callaway; Eyal Golan; Heather Herren; Jamie Jasti; Peter J Kudenchuk; Damon C Scales; Dion Stub; Derek K Richardson; Dana M Zive Journal: Resuscitation Date: 2016-02-03 Impact factor: 5.262
Authors: Tamil S Anthonymuthu; Elizabeth M Kenny; Zachary E Hier; Robert S B Clark; Patrick M Kochanek; Valerian E Kagan; Hülya Bayır Journal: Exp Neurol Date: 2019-04-11 Impact factor: 5.330
Authors: Jeremy R Herrmann; Ericka L Fink; Anthony Fabio; Alicia K Au; Rachel P Berger; Keri Janesko-Feldman; Robert S B Clark; Patrick M Kochanek; Travis C Jackson Journal: Resuscitation Date: 2021-11-22 Impact factor: 5.262
Authors: Andrew M Lamade; Tamil S Anthonymuthu; Zachary E Hier; Yuan Gao; Valerian E Kagan; Hülya Bayır Journal: Exp Neurol Date: 2020-04-11 Impact factor: 5.330
Authors: Rishabh C Choudhary; Muhammad Shoaib; Samantha Sohnen; Daniel M Rolston; Daniel Jafari; Santiago J Miyara; Kei Hayashida; Ernesto P Molmenti; Junhwan Kim; Lance B Becker Journal: Front Med (Lausanne) Date: 2021-05-18
Authors: Muhammad Shoaib; Rishabh C Choudhary; Jaewoo Choi; Nancy Kim; Kei Hayashida; Tsukasa Yagi; Tai Yin; Mitsuaki Nishikimi; Jan F Stevens; Lance B Becker; Junhwan Kim Journal: Sci Rep Date: 2020-11-12 Impact factor: 4.379
Authors: Sarah L Longnus; Nina Rutishauser; Mark N Gillespie; Tobias Reichlin; Thierry P Carrel; Maria N Sanz Journal: Transplant Direct Date: 2021-12-16
Authors: Ericka L Fink; Robert S B Clark; Ashok Panigrahy; Rachel Berger; Jessica Wisnowski; Stefan Bluml; David Maloney; Pamela Rubin; Tamara Haller; Hulya Bayir; Sue R Beers; Patrick M Kochanek; Anthony Fabio Journal: BMJ Open Date: 2020-10-27 Impact factor: 2.692